Australia markets open in 5 hours 58 minutes

TC Biopharm (Holdings) Plc (TCBP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.1700+0.0900 (+8.33%)
As of 12:01PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 2.64M
Enterprise value 3.16M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.03
Price/book (mrq)1.04
Enterprise value/revenue 1.11
Enterprise value/EBITDA -2.65

Trading information

Stock price history

Beta (5Y monthly) 0.04
52-week change 3-99.88%
S&P500 52-week change 324.16%
52-week high 31,042.0000
52-week low 30.8500
50-day moving average 32.1339
200-day moving average 374.5867

Share statistics

Avg vol (3-month) 3769.84k
Avg vol (10-day) 32.82M
Shares outstanding 52.43M
Implied shares outstanding 617.23M
Float 84.6M
% held by insiders 10.14%
% held by institutions 110.23%
Shares short (31 Jan 2024) 498.01k
Short ratio (31 Jan 2024) 40.16
Short % of float (31 Jan 2024) 438.99%
Short % of shares outstanding (31 Jan 2024) 414.49%
Shares short (prior month 29 Dec 2023) 423.3k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 315 Dec 2023

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 June 2023


Profit margin -54.24%
Operating margin (ttm)-409.33%

Management effectiveness

Return on assets (ttm)-67.01%
Return on equity (ttm)-102.37%

Income statement

Revenue (ttm)2.86M
Revenue per share (ttm)29.64
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -10.98M
Net income avi to common (ttm)-1.55M
Diluted EPS (ttm)-71.4600
Quarterly earnings growth (yoy)-31.00%

Balance sheet

Total cash (mrq)1.92M
Total cash per share (mrq)0.33
Total debt (mrq)2.45M
Total debt/equity (mrq)122.09%
Current ratio (mrq)1.09
Book value per share (mrq)6.92

Cash flow statement

Operating cash flow (ttm)-12.19M
Levered free cash flow (ttm)-9.9M